期刊文献+

血浆置换在ICU的应用及疗效分析 被引量:2

Application of plasma exchange applied in ICU and analysis of its curative effect
下载PDF
导出
摘要 目的分析血浆置换技术在重症医学科(ICU)的应用现状和疗效。方法对ICU 73例行血浆置换患者的临床资料进行回顾性分析。结果 1血浆置换常见适应证依次为自身免疫性疾病、肝功能衰竭并高胆红素血症、高脂血症性胰腺炎和中毒。2凝血功能和血象发生变化:血浆置换使活化部分凝血活酶时间(APTT)和凝血酶时间(TT)略延长,纤维蛋白原(Fib)轻度下降,而对凝血酶原时间(PT)、白细胞(WBC)、血红蛋白(HGB)、血小板(PLT)无影响。3经过1~2次血浆置换治疗即可有效降低高脂血症性胰腺炎患者体内血脂水平。4血浆置换治疗过程中未出现重大不良事件,其总体治愈缓解率为63.0%,疗效最好者依次为中毒、横纹肌溶解和高脂血症性胰腺炎,疗效最差者则为肝功能衰竭并高胆红素血症。结论血浆置换安全可靠、疗效好,在ICU具有广泛的应用前景。 ObjectiveTo analyze application condition and curative effect by plasma exchange in ICU. MethodsA retrospective analysis was made on clinical data of 73 patients receiving plasma exchange.Results① Common indications of plasma exchange included autoimmune disease, hepatic failure complicated with hyperbilirubinemia, hyperlipidemic pancreatitis and toxication. ② Changes of coagulation function and hemogram: plasma exchange prolonged activated partial thromboplastin time (APTT), thrombin time (TT) and slightly reduced fibrinogen (Fib). It had no influence on prothrombin time (PT), white blood count (WBC), hemoglobin (HGB), and platelets (PLT). ③ Blood lipid level in hyperlipidemic pancreatitis patients was effectively reduced by 1~2 plasma exchange. ④ No severe adverse reactions occurred during plasma exchange, and the total cure remission rate was 63.0%. This method showed good effect in toxication, rhabdomyolysis, and hyperlipidemic pancreatitis, while its poor effect was in hepatic failure complicated with hyperbilirubinemia.ConclusionPlasma exchange is creditable, along with good curative effect. Its application prospect is bright in ICU.
出处 《中国实用医药》 2016年第13期17-19,共3页 China Practical Medicine
关键词 血浆置换 重症医学科 适应证 疗效 Plasma exchange Intensive care unit Indication Curative effect
  • 相关文献

参考文献16

  • 1Paton E, Baldwin IC. Plasma exchange in the intensive care unit: a 10 year retrospective audit. Aust Crit Care, 2014, 27(3):139-144.
  • 2Yilmaz AA, Can OS, Oral M, et al. Therapeutic plasma exchange in an intensive care unit (ICU): a 10-year, single-center experience. Transfus Apher Sci, 2011, 45(2):161-166.
  • 3Nakae H, Eguehi Y, Yoshioka T, et al. Plasma diafiltration iherapy in patients with postoperative liver failure. Ther Aphe" Dial, 2011, 15(4):406-410.
  • 4Patrono D, Paraluppi G, Perino M, et al. Posthepatectomy liver failure after simultaneous versus staged resection of colorectal cancer and synchronous hepatic metastases. G Chir, 2014, 35(3-4): 86-93,.
  • 5Lee G, Arepally GM. Anticoagulation techniques in apberesis: from heparin to citrate and beyond. J Clin Apber, 2012, 27(3):117-125.
  • 6Cordoba JP, Larrarte C, Ruiz A. Is anticoagulation required in plasmapheresis? A University Hospital Experience in Bogota, Colombia. Transfus Apher Sei, 201 3, 48(3):301-305.
  • 7Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apberesis n clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher, 2013, 28(3):145- 284.
  • 8Ramirez-Bueno A, Salazar-Ramirez C, Cota-Delgado F, et al. Plasmapheresis as treatment for hyperlipidemic pancreatitis. Eur J Intern Med, 2014, 25(2):160-163.
  • 9阿木提江·马合木提,阿布都沙拉木·阿布都热衣木,陈革.维吾尔族高脂血症性重症急性胰腺炎的临床特点及血浆置换治疗效果[J].中华外科杂志,2015,53(3):185-188. 被引量:17
  • 10Kaplan AA. Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis, 2008, 52(6):1180-1196.

二级参考文献9

  • 1KnausWA,DraperEA,WagnerDP,et al.APACHE Ⅱ:a severity of disease classification system[J].Crit Care Med,1985,13(10):818–829.
  • 2ToskesPP.Hyperlipidemic pancreatitis[J].Gastroenterol Clin North Am,1990,19(4):783–791.
  • 3EwaldN,KloerHU.Severe hypertriglyceridemia:an indication for apheresis?[J].Atheroscler Suppl,2009,10(5):49–52.
  • 4StefanuttiC,Di GiacomoS,VivenzioA,et al.Therapeutic plasma exchange in patients with severe hypertriglyceridemia:a multicenter study[J].Artif Organs,2009,33(12):1096–1102.
  • 5Salazar RamirezC,Daga RuizD,Cota DelgadoF,et al.Utility of plasmapheresis in intensive care[J].Med Intensiva,2010,34(1):74–78.
  • 6EwaldN,KloerHU.Treatment options for severe hypertriglyceridemia(SHTG):the role of apheresis[J].Clin Res Cardiol Suppl,2012,7(Suppl 1):31–35.
  • 7Ramírez–BuenoA,Salazar–RamírezC,Cota–DelgadoF,et al.Plasmapheresis as treatment for hyperlipidemic pancreatitis[J].Eur J Intern Med,2014,25(2):160–163.
  • 8StefanuttiC,LabbadiaG,MorozziC.Severe hypertriglyceridemia–related acute pancreatitis[J].Ther Apher Dial,2013,17(2):130–137.
  • 9孙玉萍,李清,姚华,王秋云,胡静,艾森拉江.买买提艾力,蔡志华.维吾尔族居民血脂及高脂血症分析[J].中国公共卫生,2010,26(3):271-272. 被引量:10

共引文献16

同被引文献28

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部